The mast cell: An active participant or an innocent bystander?

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 259-270

  Crivellato, Enrico ^a   Beltrami, C A ^a   Mallardi, F ^a   Ribatti, D ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

Function; Mast cell; Pathology; Structure

Indexed keywords

CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; FIBROBLAST GROWTH FACTOR 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 14; INTERLEUKIN 16; INTERLEUKIN 18; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN 9; LYMPHOTACTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MEMBRANE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NERVE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ALLERGIC DISEASE; ANGIOGENESIS; CELL FUNCTION; CELL STRUCTURE; FIBROSIS; HISTOPATHOLOGY; HOMEOSTASIS; HOST PARASITE INTERACTION; HOST RESISTANCE; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATION; MAST CELL; MASTOCYTOMA; MULTIPLE SCLEROSIS; NERVE CELL NETWORK; NONHUMAN; PHYLOGENY; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SECRETORY GRANULE; SPLEEN; TISSUE REPAIR;

ANIMALS; CYTOKINES; FIBROSIS; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INFLAMMATION; INFLAMMATION MEDIATORS; MAST CELLS; NEOPLASMS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVOUS SYSTEM PHYSIOLOGY; RECEPTORS, IMMUNOLOGIC;

EID: 1642515016     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (88)

1. Aloe L. and Levi-Montalcini R. (1977). Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res. 133, 358-366.
2. Artuc M., Hermes B., Steckelings M.U., Grutzkau A. and Henz B.M. (1999). Mast cells and their mediators in wound-healing - Active participants or innocent bystanders? Exp. Dermatol. 8, 1-16.
3. Artuc M., Steckelings M. and Henz B.M. (2002). Mast cell-fibroblast interactions: Human mast cells as source and inducer of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118, 391-395.
4. Benoist C. and Mathis D. (2002). Mast cells in autoimmune disease. Nature 420, 875-878.
5. Blair R.J., Meng H., Marchese M.J., Ren S., Schwartz L.B. and Tonnesen M.G. (1997). Human mast cells stimulate vascular tube formation: Tryptase is a novel potent angiogenic factor. J. Clin. Invest. 99, 2691-2700.
6. Bochner B.S. and Schleimer R.P. (2001). Mast cells, basophils, and eosinophils: Distinct but overlapping pathways for recruitment. Immunol. Rev. 179, 5-15.
7. Bochner B.S., Charlesworth E.N., Lichtenstein L.M., Derse C.P., Gillis S., Dinarello C.A. and Schleimer R.P. (1990). Interleukin-1 is released at sites of human cutaneous allergic reactions. J. Allergy Clin. Immunol. 86, 830-839.
8. Bonini S.E., Lambiase A., Bonini S., Angelucci F., Magrini L., Manni L. and Aloe L. (1996). Circulating nerve growth factor levels are increased in human with allergic diseases and asthma. Proc. Natl. Acad. Sci. USA 93, 10955-10960.
9. Bradding P., Feather I.H., Wilson S., Bardin P.G., Heusser C.H., Holgate S.T. and Howarth P.H. (1993). Immonolocalization of cytokines in the nasal mucosa of normal and perennial rhinitic subjects. The mast cell as a source of IL-4, IL-5, and IL-6 in human allergic mucosal inflammation. J. Immunol. 151, 3853-3865.
10. Bradding P., Okayama Y., Howzrth P.H. and Church M.K. (1995). Heterogeneity of human mast cells based on cytokine content. J. Immunol. 155, 297-307.
11. Cairns J.A. and Walls A.F. (1997). Mast cell tryptase stimulate the synthesis of type I collagen in human lung fibroblasts. J. Clin. Invest. 99, 1313-1321.
12. Chen R., Fairley J.A., Zhao M.L., Giudice G.J., Zillikens D., Diaz L.A. and Lin Z. (2002). Macrophages, but not T and B lymphocytes, are critical for subepidermal blister formation in experimental bullous pemphigoid: Macrophage-mediated neutrophil infiltration depends on mast cell activation. J. Immunol. 169, 3987-3992.
13. Church M.K. and Levi-Schaffer F. (1997). The human mast cell. J Allergy Clin. Immunol. 99, 155-160.
14. Columbo M., Bochner B.S. and Marone G. (1995). Human skin mast cells express function β1 integrins that mediate adhesion to extracellular matrix proteins. J. Immunol. 154, 6058-6064.
15. Conti P., Kempuraj D., Di Gioacchino M., Boucher W., Letourneau R., Kandere K., Barbacane R.C., Reale M., Felaco M., Frydas S. and Theoharides T.C. (2002). Interleukin-6 and mast cells. Allergy Asthma Proc. 23, 331-335.
16. Crivellato E., Damiani D., Mallardi F. and Travan L. (1991). Suggestive evidence for a microanatomical relationship between mast cells and nerve fibres containing substance P, calcitonin gene related peptide, vasoactive intestinal polypeptide, and somatostatin in the rat mesentery. Acta Anat. (Basel) 141, 127-132.
17. Crivellato E., Nico B., Vacca A., Dammacco F. and Ribatti D. (2002). Mast cell heterogeneity in B-cell non-Hodgkin's lymphoma. An ultrastructural study. Leuk. Lymph. 43, 2201-2205.
18. Crivellato E., Finato N., Isola M., Ribatti D. and Beltrami C.A. (2003). Low mast cell density in the human duodenal mucosa from chronic inflammatory duodenal bowel disorders is associated with defective villous architecture. Eur. J. Clin. Invest. 33, 601-610.
19. Dropp J.J. (1979). Mast cells in the human brain. Acta Anat. (Basel) 105, 505-513.
20. Dvorak A.M. (1991). Basophil and mast cell degranulation and recovery. Blood Cell Biochemistry. Vol. 4. Harris J.R. (ed). Plenum Press. New York.
21. Dvorak A.M. and Kissel S. (1991). Granule changes of human skin mast cells characteristic of piecemeal degranulation and associated with recovery during wound healing in situ. J. Leuk. Biol. 49, 197-210.
22. Dvorak A.M. and Morgans E.S. (2000). Ultrastructural immonogold cytochemistry with autoimmune human sera and an antibody to uridine implicate human mast cell granules in RNA biology. Histochem. J. 32, 685-696.
23. Dvorak A.M., Morgan E.S. and Weller P.F. (2003). RNA is closely associated with human mast cell lipid bodies. Histol. Histopathol. 18, 943-968.
24. Ehrlich P. (1878). Beiträge zur Theorie und Praxis der Histologischen Färbung. Thesis. Leipzig University.
25. Elbadawi A. (1997). Interstitial cystitis: A critique of current concepts with a new proposal for pathologic diagnosis and pathogenesis. Urology 49 (Supplementum 5A), 14-40.
26. Esposito P., Chandler N., Kandere K., Basu S., Jacobson S., Connolly R., Tutor D. and Theoharides T.C. (2002). Corticotropin-releasing hormone and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303, 1061-1066.
27. Foreman J.C. and Jordan C.C. (1980). Comparison of the activities of some peptides in human skin and as histamine releasing agents. Proc. Br. Pharmacol. Soc. (Lond) C57, 55.
28. Frangogiannis N.G., Lindsey M.L., Michael L.H., Youker K.A., Bressler R.B., Mendoza L.H., Spengler R.N., Smith C.W. and Entman M.L. (1998). Resident cardiac mast cells degranulate and release preformed TNF-α, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 98, 699-710.
29. Fureder W., Agis H., Willheim M., Bankl H.C., Maier U., Kishi K., Muller M.R., Czerwenka K., Radaszkiewicz T. and Butterfield J.H. (1995). Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155, 3152-3160.
30. Galli S.J. (1990). New insight into "the riddle of mast cells": Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab. Invest. 62, 5-33.
31. Galli S.J. (1997). Complexity and redundancy in the pathogenesis of asthma: Reassessing the roles of mast cells and T cells. J. Exp. Med. 186, 343-347.
32. Gruber B.L., Marchese M.J. and Kew R.R. (1994). Transforming growth factor-β1 mediates mast cell chemotaxis. J. Immunol. 152, 5860-5867.
33. Gruber B.L., Kew R.R., Jelaska A., Marchese M.J., Garlick J., Ren S., Schwartz W.B. and Korn J.H. (1997). Human mast cells activate fibroblasts. J. Immunol. 158, 2310-2317.
34. Gruber B.L., Marchese M.J. and Kew R. (1995). Angiogenic factors stimulate mast cell migration. Blood 86, 2488-2493.
35. Grutzkau A., Kruger-Krasagakes S., Baumesteir H., Schwarz C., Kogel H., Welker P., Lippert U., Henz B.M. and Moller A. (1998). Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: Implications for the biological significance of VEGF 206. Mol. Biol. Cell. 9, 875-884.
36. Gurish M.F. and Austen K.F. (2001). The diverse role of mast cells. J. Exp. Med. 194, 1-5.
37. Guy-Grand D., Dy M., Luffau G.a nd Vassalli P. (1984). Gut mucosal mast cells. Origin, traffic and differentiation. J. Exp. Med. 160, 12-28.
38. Hartmann K., Henz B.M., Kruger-Krasagakes S., Kohl M.J., Burger R., Guhl S., Haase I., Lippert U. and Zuberbier T. (1997). C3a and C5a stimulate chemotaxis of human mast cells. Blood 89, 2863-2870.
39. Irani A.M. and Schwartz L.B. (1994). Human mast cell heterogeneity. Allery Proc. 15, 303-308.
40. Irani A.M., Schechter N.M., Craig S.S., De Blois G. and Schwzrtz L.B. (1986). Two types of human mast cells that have distinct neutral protease composition. Proc. Natl. Acad. Sci. USA 83, 4464-4468.
41. Ishizaka T. and Ishizaka K. (1984). Activation of mast cells for mediator release through IgE receptor. Prog. Allergy 34, 188-235.
42. Javed N.H., Wang Y.Z. and Cooke H.J. (1992). Neuroimmune interactions: Role for cholinergic neurons in intestinal anaphylaxis. Am. J. Physiol. 263, G847-852.
43. Kenny P.A., Mc Donald P.J. and Finlay-Jones J.J. (1993). The effect of cytokines on bactericidal activity of murine neutrophils. FEMS Immunol. Med. Microbiol. 7, 271-279.
44. Kirschenbaum A.S., Kessel S.W., Goff J.P. and Metcalfe D.D (1991). Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells. J. Immunol. 146, 1410-1415.
45. Kitamura Y. (1989). Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59-76.
46. Liebler J.M., Picou M.A., Qu Z., Powers M.R. and Rosembaum J.T. (1997). Altered immunohistochemical localization of basic fibroblast growth factor after bleomycin-induced lung injury. Growth Factors 14, 25-38.
47. Lorentz A. and Bischoff S.C. (2001). Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol. Rev. 179, 57-60.
48. Malaviya R. and Abraham S.N. (2001). Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179, 16-24.
49. Malaviya R., Ikeda T., Ross E. and Abraham S.N. (1996). Mast cell modulation of neutrophil influx and bacterial clearance as sites of infection through TNF-alpha. Nature 381, 77-80.
50. Marone G., Florio G., Triggiani M., Petraroli A. and De Paulis A. (2000). Mechanisms of IgE elevation in HIV-1 infection. Crit. Rev. Immunol. 20, 477-496.
51. Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanamoto T., Suzuki H. and Kitamura Y. (1991). Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 174, 7-14.
52. Matsumoto I., Inoue Y., Shimada T. and Aikama T. (2001). Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J. Exp. Med. 194, 71-78.
53. McCurdy J.D., Olynych T.J., Maher L.H. and Marshall J.S. (2003). Cutting edge: Distinct toll-like receptor 2 activators selectivity induce different classes of mediator production from human mast cells. J. Immunol. 170, 1625-1629.
54. Meininger C.J., Brightman S.E., Kelly K.A. and Zetter B.R. (1995). Increased stem cell factor release by hemangioma-derived endothelial cells. Lab. Invest. 72, 48-52.
55. Mekori Y.A. and Metcalfe D.D. (2000). Mast cells in the innate immunity. Immunol. Rev. 173, 131-140.
56. Metcalfe D.D., Baram D. and Mekori Y.A. (1997). Mast cells. Physiol. Rev. 77, 1033-1079.
57. Moller A., Lippert U., Lessmann D., Kolde G., Hamann K., Welker P., Schadendorf D., Rosenbach T., Luger T. and Czarnetzki B.M. (1993). Human mast cells produce IL-8. J. Immunol. 151, 3261-3266.
58. Nickel R., Beck L.A., Stellato C. and Schleimer R.P. (1999). Chemokines and allergic disease. J. Allergy Clin. Immunol. 104, 723-742.
59. Nilsson G., Forsberg-Nilsson K., Xiang Z., Hallbook F., Nilsson K. and Metcalfe D.D. (1997). Human mast cells express functional TrkA and are a source of nerve growth factor. Eur. J. Immunol. 27, 2295-2301.
60. Olsson N., Ulfgren A.K. and Nilsson G. (2001). Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients. Ann. Rheum. Dis. 60, 187-193.
61. Qu Z., Liebler J.M., Powers M.R., Galey T., Ahmadi P., Huang X.N., Ansel J.C., Butterfield J.H., Planck S.R. and Rosenbaum J.T. (1995). Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am. J. Pathol. 147, 547-564.
62. Ra C., Yasuda M., Yagita H. and Okumura K. (1994). Fibronectin receptor integrins are involved in mast cell activation. J. Allergy Clin. Immunol. 99, 625-628.
63. Ribatti D., Roncali L., Nico B. and Bertossi M. (1987). Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane. Acta Anat. (Basel) 130, 257-263.
64. Ribatti D., Vacca A., Nico B., Quondamatteo F., Ria R., Minischetti M., Marzullo A., Herken R., Roncali L. and Dammacco F. (1999). Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma. Br. J. Cancer 79, 451-455.
65. Ribatti D., Polimeno G., Vacca A., Marzullo A., Crivellato E., Nico B., Lucarelli G. and Dammacco F. (2002). Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16, 1596-1602.
66. Ribatti D., Molica S., Vacca A., Nico B., Crivellato E., Roccaro A.M. and Dammacco F. (2003a). Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (in press).
67. Ribatti D., Vacca A., Marzullo A., Nico B., Ria R., Roncali L. and Dammacco F. (2000). Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Int. J. Cancer 85, 171-175.
68. Ribatti D., Vacca A., Ria R., Marzullo A., Nico B., Filotico R., Roncali L. and Dammacco F. (2003b). Neovascularization, expression of fibroblast growth factor-2 and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur. J. Cancer 39, 666-674.
69. Rodewald H.R., Dessing M., Dvorak A.M. and Galli S.J. (1996). Identification of a committed precursor for the mast cell lineage. Science 271, 818-822.
70. Romagnani P., De Paulis A., Beltrame C., Annunziato F., Dente V., Maggi E., Romagnani S. and Marone G. (1999). Tryptase-chymase double positive human mast cells express the eotaxin receptor (CCR3) and are attracted by CCR3-binding chemokines. Am. J. Pathol. 155, 1195-1204.
71. Ruoss S.J., Hartmann T. and Caughey G.H. (1991). Mast cell tryptase is a mitogen for cultured fibroblasts. J. Clin. Invest. 88, 493-499.
72. Schwartz L.B., Irani A.A., Roller K., Castells M.C. and Schechter N.M. (1987). Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells. J. Immunol. 138, 2611-2615.
73. Seibold J.R., Giorno R.C. and Claman H.N. (1990). Dermal mast cell degranulation in systemic sclerosis. Arthritis Rheum. 33, 1702-1709.
74. Serafin W.E. and Austen K.F. (1989). Mediators of immediate hypersensitivity reactions. N. Engl. J. Med. 317, 30-34.
75. Shanahan F., Denburg J.A., Fox J., Bienenstock J. and Befus D. (1985). Mast cell heterogeneity: Effect of neuroenteric peptides on histamine release. J. Immunol. 135, 1331-1337.
76. Sillaber C., Baghestanian M., Hofbauser R., Virgolini I., Bankl H.C., Fureder W., Agis H., Willheim M., Leimer M., Scheiner O., Binder B.R., Kiener H.P., Bevec D., Fritsch G., Majdic O., Kress H.G., Gadner H., Lechner K. and Valent P. (1997). Molecular and functional characterization of the urokinase receptor on human mast cells. J. Biol. Chem. 272, 7824-7832.
77. Sorbo J., Jakobson A. and Norrby K. (1994). Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2. Int J. Exp. Pathol. 75, 43-50.
78. Stassen M., Hultner L. and Schmitt E. (2002). Classical and alternative pathways of mast cell activation. Crit. Rev. Immunol. 22, 115-140.
79. Stead R.H., Dixon M.F., Bramwell N.H., Riddell R.H. and Bienenstock J. (1989). Mast cells are closely apposed to nerves in the human gastrointestinal mucosa. Gastroenterology 97, 575-585.
80. Stead R.H., Kosecka-Janiszewska U., Oestreicher A.B., Dixon M.F. and Bienenstock J. (1991). Remodeling of B-50 (GAP-43)- and NSE-immunoreactive mucosal nerves in the intestines of rats infected with Nippostrngylis brasiliensis. J. Neurosci. 11, 3809-3821.
81. Stead R.H., Tomioka M., Quinonez G., Simon G.T., Felten S.Y. and Bienenstock J. (1987). Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc. Natl. Acad. Sci. USA 84, 2975-2987.
82. Taipale J., Lohi J., Saarinen J., Kovanen P.T. and Keski-Oja J. (1995). Human mast cell chymase and leukocyte elastase release latent transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270, 4689-4696.
83. Thabrew H., Cairns J.A. and Walls A.F. (1996). Mast cell tryptase is a growth factor for human airway smooth muscle. J. Allergy Clin. Immunol. 97, 969.
84. Valent P. and Bettelheim P. (1992). Cell surface structures on human basophils and mast cells: Biochemical and functional characterization. Avd. Immunol. 52, 324-333.
85. Vliagolftis H. and Metcalfe D.D. (1997). Cell adhesion molecules in mast cell adhesion and migration. In: Adhesion Molecules in Allergic Diseases. Bochner B.S. (ed.). Marcel Dekker, Inc. New York. pp. 151-72.
86. Walsh L.J., Trinchieri G., Waldorf H.A., Whiraker D. and Murphy G.F. (1991). Human dermal mast cells contain and release tumor necrosis factor alpha, which induces endothelial leukocyte adhesion molecule 1. Proc. Natl. Acad. Sci. USA 88, 4220-4224.
87. WHO Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. (2001). Jaffe E.S., Harris N.L., Stein H. and Vardiman J.W. (eds). IARC Press. Lyon. pp 291-302.
88. Zappulla J.P., Arock M., Mars L.T. and Liblau R.S. (2002). Mast cells: New targets for multiple sclerosis therapy? J. Neuroimmunol. 131, 5-20.